Table 3.
Literature review of the leukemia patients with IPA
| Patients | Period | Underlying disease | Operative procedure (%) | Operative mortality/morbidity (%) | Histology for Aspergillus (%) | Author |
|---|---|---|---|---|---|---|
| 16 | 1987–1993 | AML (14), LTX (2) | P (12.5), L (62.5), W (25) | 31.2/12.5 | 56.3 | Robinson et al18 |
| 15 | 1988–1997 | AML (15) | L (53), W (47) | 6.7/13.2 | 100 | Bernard et al19 |
| 18 | 1988–1996 | AML (13), ALL (3), Myeloma( 2) | P (5.6), L (61.1), W (33.3) | 0/unknown | 66.6 | Baron et al20 |
| 27 | 1983–1997 | AML (11), ALL (4), AA (7), CML (3), NHL (1), MDS (1) |
L (74), W (26) | 1.4/18.5 | 81.5 | Reichenberger et al21 |
| 13 | 1986–1996 | AML (6), ALL (3), MDS (1), HL (1), AA (1), MM (1) |
L (34), W (77) | 7.6/7.6 | n.g | Salerno et al22 |
| 13 | 1988–1998 | AML (6), ALL (6), breast cancer (1) | P (7.6), L (30.8), W (61.6) | 15.3/15.3 | 76 | Pidhorecky et al23 |
| 35 | 1982–1995 | n.g, all patients received BMT | P (11), L (89) | 22.8/11.4 | 100 | Yeghen.et al24 |
| 10 | 1991–2000 | AML(6), ALL(3) | L (80), W (20) | 0/20 | 40 | Al-Kattan et al25 |
| 41 | 1983–2002 | A/CML (26), AA (7), NHL (8) | L (56), W (39), E (5) | 10/10 | 75.6 | Matt et al26 |
| 10 | 2001–2007 | AML (4), ALL (4), LTx (1), NHL(1) | L (60), W (40) | 20/10 | 60 | Danner et al5 |
Abbreviations: A/CML, acute/chronic myeloid leukaemia; ALL, acute lymphoblastic leukemia; (N)HL, (Non)Hodgkin lymphoma; AA, aplastic anemia; MM, multiple myeloma; BMT, bone marrow transplantation; LTx, liver transplantation; MDS, myelodysplastic syndrome; P, pneumectomy; L, lobectomy; W, wedge resection/segmentectomy; E, enucleation; n.g., not given; po, postoperative.